Scope: Adult polymorphic ventricular tachycardia. For sustained episodes, immediate unsynchronized shock takes priority over QT analysis. Subsequent treatment depends on the baseline QT, cause and specialist assessment.
The key question is not “Is the QRS changing?”
The key question is:
Is the QT interval prolonged or not?
Assess the QTc on an ECG after termination and compare previous tracings. The QT during polymorphic VT is not interpretable; do not delay a shock to measure it.
Polymorphic VT in one sentence
It may:
- stop on its own and come back,
- become sustained,
- or degenerate into ventricular fibrillation (VF).
In fact, VF often starts as polymorphic VT, and prolonged pVT often becomes VF.
The bedside rule
Sustained polymorphic VT = immediate unsynchronized shock
Unlike monomorphic VT, you usually cannot reliably synchronize because the QRS keeps changing.
So the electrical treatment is:
High-energy unsynchronized shock (defibrillation), using the maximum manufacturer setting.
Not synchronized cardioversion.
Two major clinical classifications
1) Polymorphic VT with prolonged QT = torsades de pointes
This is the classic form everyone remembers.
Why it happens physiologically
A prolonged QT means delayed ventricular repolarization.
That creates electrical instability and allows early afterdepolarizations, which can trigger torsades.
It is more likely when:
- QTc > 500 ms
- especially with bradycardia
- plus triggers like:
- QT-prolonging drugs
- hypokalemia
- hypomagnesemia
- congenital long QT syndromes
Clinical pattern
Torsades often comes in bursts:
- starts
- self-terminates
- recurs again and again
So even if you shock it successfully, it may come right back unless you resolve the underlying substrate.
Treatment priorities
Sustained polymorphic VT requires immediate high-energy unsynchronized shock, including when a pulse is present; do not wait for hypotension or QT analysis. If the episode has already self-terminated, treat the cause and prevent recurrence with continuous monitoring and immediate defibrillation capability. If pulseless, follow the cardiac-arrest algorithm with CPR. AHA 2025 ALS guidance.
IV magnesium sulfate may be used for recurrent long-QT torsades, even when the measured magnesium is normal. Use the appropriate monitored adult protocol; magnesium must not delay defibrillation of sustained polymorphic VT.
Correct potassium and magnesium abnormalities with monitored replacement. Set targets, replacement rates and upper limits under the local protocol, considering renal function and repeat measurements. Verify laboratory units; magnesium values in mg/dL and mmol/L are not interchangeable. See ERC electrolyte guidance.
Stop QT-prolonging drugs.
If associated with bradycardia/pause dependence, consider:
- Overdrive pacing.
- Isoproterenol: Reserve consideration for recurrent, pause-dependent torsades associated with acquired long QT, under expert guidance after magnesium and correction of triggers; pacing is another option. Avoid isoproterenol in acute coronary ischemia and do not extrapolate this approach to congenital long-QT syndromes or catecholaminergic polymorphic VT (CPVT). Those conditions require disease-specific specialist management, often including beta-blockade. ESC 2022 ventricular-arrhythmia guidance.
- Expert consultation.
Important pitfall
Many antiarrhythmics can worsen torsades because they prolong QT further.
So in torsades:
- magnesium may suppress recurrences
- QT-prolonging antiarrhythmics may hurt
Also, acute beta-blockade can worsen bradycardia, so in pause-dependent torsades it may aggravate the problem. This warning concerns pause-dependent acquired long QT; beta-blockers remain central to congenital long-QT and CPVT treatment.
2) Polymorphic VT without prolonged QT
These are simplified mechanistic sketches. Changing QRS morphology alone cannot identify the number of foci or exit sites.
Most common cause
Acute myocardial ischemia/infarction
Physiology
Unlike long-QT torsades, normal-QT polymorphic VT is not defined by delayed global repolarization. Ischemia is common, but inherited or idiopathic mechanisms remain possible.
Treatment priorities
- Immediate defibrillation for sustained polymorphic VT
- Treat the ischemia
- For recurrences without QT prolongation, consider:
- lidocaine
- amiodarone
- Beta-blockers may help when ischemia is the driver; assess perfusion, heart failure, bradycardia and conduction disease before use.
- Consider emergent coronary reperfusion when appropriate
Important pitfall
Routine magnesium is not recommended for normal-QT polymorphic VT. Correct documented magnesium deficiency as a separate problem.
The most important practical distinction
Torsades
Think:
- long QT
- often bradycardia/pause-triggered
- magnesium
- correct electrolytes
- expert-guided pacing or selected isoproterenol for recurrent pause-dependent torsades with acquired long QT; use disease-specific management for congenital long-QT syndromes
- avoid QT-prolonging drugs
Non–long-QT polymorphic VT
Think:
- urgent assessment for ischemia and other causes
- defibrillate sustained polymorphic VT
- treat ACS / MI when present
- lidocaine or amiodarone may help
- beta-blockade may help if ischemia-driven
A memorable one-liner
For sustained polymorphic VT, shock immediately. Once the episode ends, use the baseline QT to guide recurrence prevention.
Because:
- Long QT → torsades → magnesium and trigger correction; consider expert-guided rate acceleration for recurrent pause-dependent acquired long QT
- Normal QT → assess urgently for ischemia and other causes; defibrillate sustained pVT and treat the identified mechanism
Bedside pearls
- All polymorphic VT is unstable
- It is often hard to distinguish from VF
- Sustained polymorphic VT requires immediate unsynchronized shock, even with a pulse; do not wait for hypotension or QT analysis
- Shocking terminates the episode, but does not fix the cause
- Magnesium is for torsades, not for all polymorphic VT
Simple algorithm
- Recognize polymorphic ventricular tachycardia.
- Treat as unstable.
- Consider brief procedural sedation if conscious and feasible, without delaying the shock.
- Deliver high-energy unsynchronized shock.
- Ask: Is the baseline QT interval prolonged?
- Yes (Known long QT): Give IV magnesium, correct potassium and magnesium abnormalities with monitored replacement, and stop QT-prolonging drugs. Consider expert-guided pacing for recurrent pause-dependent acquired long QT.
- No (Known normal QT): Urgently assess for ischemia and other causes; a normal QT alone does not establish ACS. Treat ischemia when indicated. Lidocaine or amiodarone may be considered for recurrences, and beta-blockade may help when ischemia is the driver; select treatment according to the cause and specialist assessment.
- Unknown baseline QT: Sustained polymorphic VT requires immediate unsynchronized shock. After termination, assess the ECG, prior tracings, medications, electrolytes and ischemia. If long-QT torsades is suspected, use magnesium and avoid QT-prolonging antiarrhythmics while seeking expert advice. Unknown QT does not establish an ischemic mechanism or automatically justify amiodarone. (AHA 2025, polymorphic VT)
An irregular wide-complex rhythm may instead be pre-excited atrial fibrillation. This algorithm assumes polymorphic VT; obtain expert rhythm assessment when uncertain.
Bidirectional VT deserves special mention.
It is a distinctive form of ventricular tachycardia where the QRS axis or morphology alternates from beat to beat. Unlike classic torsades, it should immediately raise suspicion for specific diagnoses, most notably digoxin toxicity and catecholaminergic polymorphic VT (CPVT). More rarely, it can be seen in conditions such as Andersen–Tawil syndrome or myocarditis.
For suspected digoxin toxicity, stop digoxin and seek urgent toxicology advice. Life-threatening digoxin toxicity requires digoxin immune Fab; reassess electrolytes and renal function. In CPVT, reduce adrenergic stress and obtain electrophysiology guidance. Nonselective beta-blockers are first-line treatment; flecainide may be added for persistent arrhythmias. These disease-specific treatments are not interchangeable.
The R-on-T phenomenon also deserves attention.
This phenomenon helps explain how malignant ventricular arrhythmias begin. It occurs when a premature ventricular beat falls directly on the T wave, meaning it arrives during the vulnerable phase of repolarization before the ventricle has fully reset. Consequently, this poorly timed impulse can trigger polymorphic VT, torsades de pointes, or even ventricular fibrillation.
R-on-T is a trigger, not a diagnosis. Interpret it with the QTc, preceding pauses, symptoms, drugs, electrolytes and evidence of ischemia. A single tracing cannot quantify an individual’s risk. QT morphology and the clinical context matter.
Final thoughts
Polymorphic VT is more than an ECG pattern. It is a sign of electrical instability. The most important question is simple: is the QT interval prolonged? A long QT points toward torsades. A normal QT points more toward ischemia or another arrhythmic substrate.
Some patterns offer even more clues. Bidirectional VT should raise suspicion for diagnoses such as digoxin toxicity or CPVT. The R-on-T phenomenon should be recognized as a trigger, not a diagnosis. It shows how a poorly timed ventricular beat can ignite a dangerous arrhythmia.
The final lesson is straightforward. Do not stop at naming the rhythm. Do not stop at terminating the episode. Check the QT. Look for the trigger. Identify the substrate. Then treat the mechanism.
After rhythm control, continue monitored inpatient care and cardiology assessment. Document culprit drugs and arrange evaluation for inherited disease when the history or ECG suggests it.
By Dr. Abdolghader Pakniyat, Peer-reviewed by Dr. Sabrina Berdouk
